Saama Blog

Big Data Insights on Saama solutions and services

Saama to the Rescue: Data Manager

By Luke Stewart | October 18, 2018

Saama continues our new blog series, “Saama to the Rescue,” in which we profile common, real-life challenges encountered by various levels of clinical trial leadership every day, and how Saama solutions can pave the way for more efficient and effective clinical operations. We recognize that, in any clinical study, trial leadership at every level have…

Read More

Cost Considerations: Critical for Clinical Trials

By John Fox | October 15, 2018

Saama is pleased to continue our Clinical Trial Excellence for Tomorrow and Beyond blog series, each installment of which will be authored by one of our six new Clinical Board of Advisor members. This week, John Fox, Vice President of Global Payroll at Johnson & Johnson and Vice President of Information Technology at Pharmaceuticals Group, addresses the financial considerations that…

Read More

Bring a drug to market 1 year early, save $85M along the way

By Amit Gulwadi | October 11, 2018

This is Part #1 of a blog series describing how disruptive innovation technologies such as Saama’s Life Science Analytics Cloud is enabling the Pharma industry to bend its clinical development cost curve sharply downwards while bringing cures to patients sooner. Co-authored by Nekzad Shroff,  Vice President for Business Consulting and Enablement and Amit Gulwadi,  Senior Vice…

Read More

Saama to the Rescue: The Clinical Trial Manager’s Trials

By Dr. Anand Dubey | October 10, 2018

Saama continues our new blog series, “Saama to the Rescue,” in which we profile common, real-life challenges encountered by various levels of clinical trial leadership every day, and how Saama solutions can pave the way for more efficient and effective clinical operations. We recognize that, in any clinical study, trial leadership at every level have…

Read More

Streamlining Clinical Trials for the Future

By Scot Harper | October 8, 2018

Saama is pleased to continue our Clinical Trial Excellence for Tomorrow and Beyond blog series, each installment of which will be authored by one of our six new Clinical Board of Advisor members. This week, Scot Harper, Ph.D., President of SLH Group, a life sciences consulting company and previously CEO of Novartis Clinical Operations, address some steps life science industry clinical…

Read More

Open Innovation and Co-Innovation

By Sagar Anisingaraju | October 2, 2018

Saama’s Chief Strategy Officer Sagar Anisingaraju, recently attended the World Forum Disrupt Open Innovation Strategy & Conference in San Francisco, September 18-19, 2018, and participated in a panel on Open Innovation and Co-Innovation, hosted by Pamela Rice, FinTech Executive, Advisor and Innovator. Below are excerpts from Sagar’s discussion points on that topic. Pamela Rice: We are…

Read More

Clinical Development; “A Futuristic View”

By Stephen Cunningham | October 1, 2018

Saama is pleased to continue our Clinical Trial Excellence for Tomorrow and Beyond blog series, each installment of which will be authored by one of our six new Clinical Board of Advisor members. This week, Stephen Cunningham, M.D., President, SRC Pharma Consult; former Chief Scientific Officer and Head of U.S. Clinical Development, Medical Affairs and Evidence-Based Medicine, Novartis, discusses the types…

Read More

Saama to the Rescue: The Portfolio Lead’s Dilemma

By Luke Stewart | September 27, 2018

In any clinical study, trial leadership at every level have an abundance of details to manage, people to supervise, deadlines to meet, and budgets administer, among other things. What trial leadership does not have is an abundance of time to solve the inevitable challenges that arise in relation to these various moving parts. Saama can…

Read More

Saama Clinical Trial Excellence for Tomorrow and Beyond Blog Series Installment 2

By Opinder Bawa | September 24, 2018

Saama is pleased to continue our Clinical Trial Excellence for Tomorrow and Beyond blog series, each installment of which will be authored by one of our six new Clinical Board of Advisor members. This week, Opinder Bawa, Vice President and Chief Information Officer at the University of San Francisco and former UCSF Chief Technology Officer, discusses what technology developments and…

Read More

Partnerships for Optimizing Clinical Trial Success

By Jonathan Zung | September 17, 2018

Saama is proud to kick-off the first installment of our Clinical Trial Excellence for Tomorrow and Beyond blog series, each of which will be authored by one of Saama’s six new Clinical Board of Advisors members. This week, Jonathan Zung, Ph.D. President of Clintrax and former Group President of Clinical Development & Commercialization Services at Covance Drug Development, offers…

Read More

Clinical Trial Excellence for Tomorrow and Beyond: Part 1

By Ken Massey | September 10, 2018

As part of our continually expanding footprint as a data analytics leader, Saama is pleased to announce the addition of six new life science industry luminaries to our Clinical Board of Advisors: Opinder Bawa, Vice President and Chief Information Officer, University of San Francisco; former Chief Technology Officer, UCSF. Stephen Cunningham, M.D., President, SRC Pharma…

Read More

How Saama Went from the “Seduction of More” to the “Wisdom of Less” – A Case Study from Kellogg School of Management

By Mohanbir Sawhney | August 9, 2018
Professor Sawhney from Kellogg Business School talks about Saama

In my advisory work with startups and mature companies undergoing a transformation, I have found that they often pursue growth opportunities in an undisciplined manner and end up spreading themselves too thin. In the relentless pursuit of growth, no opportunity is passed up and no customer is turned away. However, growth is not about doing…

Read More

Movidius: The Next Big Leap In Machine Learning Inference For Edge Computing?

By Soham Chatterjee | July 27, 2018

Soham Chatterjee makes a case for moving large computations to the Edge instead of wasting bandwidth and other resources for backing of every type of data on the cloud. He further explains how to do it using a Raspberry Pi and the Intel Neural Compute Stick (NCS), a low power USB stick size device that can be used to run machine learning model inference on the Edge.

Read More

Saama’s LSAC Featured on Amazon AWS web series ‘This is My Architecture’

By Krunal Patel | June 1, 2018

Krunal Patel, Saama’s Head of Engineering & Architecture, was invited to talk about Life Science Analytics Cloud (LSAC) on a segment on Amazon’s web series This is My Architecture, which highlights innovative architectures developed by its partners and customers using the scalable and flexible AWS cloud.

Read More

2 Key Ways in Which Blockchain Can Enable Pharmaceutical Manufacturing and Supply Chain

By Tushar Sinkar | May 24, 2018

Building on the advantages of blockchain technology, Tushar Sinkar take a step forward to discuss ways in which blockchain can enable Pharmaceutical Manufacturing and Supply Chain. He presents use cases to establish blockchain’s ability to combat counterfeit drug production and its contribution in Autologous Therapy, which requires a high level of confidentiality, integrity and availability.…

Read More

RSS adobe_pdf2

Archives